Clinical Research, Amyotrophic Lateral Sclerosis (ALS)
Who We Are
Biogen's mission is to be a pioneer in neuroscience. Since its founding in 1978 as one of the world's first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases. Biogen remains focused on furthering Amyotrophic Lateral Sclerosis (ALS) research and treatment.